UGT1A1 and Hyperbilirubinemia: Specifically, neonates who carried heterozygous or homozygous variation in the exon of UGT1A1 had a 2.21(95%CI:1.09–4.49) fold risk of hyperbilirubinemia as compared with those having the wild genotype (P = 0.03).